SMAD3 and pancreatitis: In our study, we found out that VARs on SMAD3 were significantly linked to the development of pancreatitis: 33% of patients with SMAD3 variants suffered from pancreatitis while the incidence of pancreatitis in the complete cohort was only 14%.